BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 26527616)

  • 1. Characterizations of Three Major Cysteine Sensors of Keap1 in Stress Response.
    Saito R; Suzuki T; Hiramoto K; Asami S; Naganuma E; Suda H; Iso T; Yamamoto H; Morita M; Baird L; Furusawa Y; Negishi T; Ichinose M; Yamamoto M
    Mol Cell Biol; 2016 Jan; 36(2):271-84. PubMed ID: 26527616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical cysteine residues of Kelch-like ECH-associated protein 1 in arsenic sensing and suppression of nuclear factor erythroid 2-related factor 2.
    He X; Ma Q
    J Pharmacol Exp Ther; 2010 Jan; 332(1):66-75. PubMed ID: 19808700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative and electrophilic stresses activate Nrf2 through inhibition of ubiquitination activity of Keap1.
    Kobayashi A; Kang MI; Watai Y; Tong KI; Shibata T; Uchida K; Yamamoto M
    Mol Cell Biol; 2006 Jan; 26(1):221-9. PubMed ID: 16354693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of the multiple sensor mechanism of the Keap1-Nrf2 system.
    Takaya K; Suzuki T; Motohashi H; Onodera K; Satomi S; Kensler TW; Yamamoto M
    Free Radic Biol Med; 2012 Aug; 53(4):817-27. PubMed ID: 22732183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Keap1-Nrf2 system as an in vivo sensor for electrophiles.
    Uruno A; Motohashi H
    Nitric Oxide; 2011 Aug; 25(2):153-60. PubMed ID: 21385624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physiological significance of reactive cysteine residues of Keap1 in determining Nrf2 activity.
    Yamamoto T; Suzuki T; Kobayashi A; Wakabayashi J; Maher J; Motohashi H; Yamamoto M
    Mol Cell Biol; 2008 Apr; 28(8):2758-70. PubMed ID: 18268004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Keap1 cysteine 288 as a potential target for diallyl trisulfide-induced Nrf2 activation.
    Kim S; Lee HG; Park SA; Kundu JK; Keum YS; Cha YN; Na HK; Surh YJ
    PLoS One; 2014; 9(1):e85984. PubMed ID: 24489685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis for defects of Keap1 activity provoked by its point mutations in lung cancer.
    Padmanabhan B; Tong KI; Ohta T; Nakamura Y; Scharlock M; Ohtsuji M; Kang MI; Kobayashi A; Yokoyama S; Yamamoto M
    Mol Cell; 2006 Mar; 21(5):689-700. PubMed ID: 16507366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Keap1 degradation by autophagy for the maintenance of redox homeostasis.
    Taguchi K; Fujikawa N; Komatsu M; Ishii T; Unno M; Akaike T; Motohashi H; Yamamoto M
    Proc Natl Acad Sci U S A; 2012 Aug; 109(34):13561-6. PubMed ID: 22872865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cysteine-based regulation of the CUL3 adaptor protein Keap1.
    Sekhar KR; Rachakonda G; Freeman ML
    Toxicol Appl Pharmacol; 2010 Apr; 244(1):21-6. PubMed ID: 19560482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Mechanism of Cellular Oxidative Stress Sensing by Keap1.
    Suzuki T; Muramatsu A; Saito R; Iso T; Shibata T; Kuwata K; Kawaguchi SI; Iwawaki T; Adachi S; Suda H; Morita M; Uchida K; Baird L; Yamamoto M
    Cell Rep; 2019 Jul; 28(3):746-758.e4. PubMed ID: 31315052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of the Nrf2/ARE pathway via S-alkylation of cysteine 151 in the chemopreventive agent-sensor Keap1 protein by falcarindiol, a conjugated diacetylene compound.
    Ohnuma T; Nakayama S; Anan E; Nishiyama T; Ogura K; Hiratsuka A
    Toxicol Appl Pharmacol; 2010 Apr; 244(1):27-36. PubMed ID: 20026152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Participation of covalent modification of Keap1 in the activation of Nrf2 by tert-butylbenzoquinone, an electrophilic metabolite of butylated hydroxyanisole.
    Abiko Y; Miura T; Phuc BH; Shinkai Y; Kumagai Y
    Toxicol Appl Pharmacol; 2011 Aug; 255(1):32-9. PubMed ID: 21651925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection against electrophile and oxidant stress by induction of the phase 2 response: fate of cysteines of the Keap1 sensor modified by inducers.
    Wakabayashi N; Dinkova-Kostova AT; Holtzclaw WD; Kang MI; Kobayashi A; Yamamoto M; Kensler TW; Talalay P
    Proc Natl Acad Sci U S A; 2004 Feb; 101(7):2040-5. PubMed ID: 14764894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Keap1, the sensor for electrophiles and oxidants that regulates the phase 2 response, is a zinc metalloprotein.
    Dinkova-Kostova AT; Holtzclaw WD; Wakabayashi N
    Biochemistry; 2005 May; 44(18):6889-99. PubMed ID: 15865434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydrogen sulfide protects against cellular senescence via S-sulfhydration of Keap1 and activation of Nrf2.
    Yang G; Zhao K; Ju Y; Mani S; Cao Q; Puukila S; Khaper N; Wu L; Wang R
    Antioxid Redox Signal; 2013 May; 18(15):1906-19. PubMed ID: 23176571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Select heterozygous Keap1 mutations have a dominant-negative effect on wild-type Keap1 in vivo.
    Suzuki T; Maher J; Yamamoto M
    Cancer Res; 2011 Mar; 71(5):1700-9. PubMed ID: 21177379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular evolution of Keap1. Two Keap1 molecules with distinctive intervening region structures are conserved among fish.
    Li L; Kobayashi M; Kaneko H; Nakajima-Takagi Y; Nakayama Y; Yamamoto M
    J Biol Chem; 2008 Feb; 283(6):3248-3255. PubMed ID: 18057000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway.
    Kensler TW; Wakabayashi N; Biswal S
    Annu Rev Pharmacol Toxicol; 2007; 47():89-116. PubMed ID: 16968214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrophilic nitro-fatty acids activate NRF2 by a KEAP1 cysteine 151-independent mechanism.
    Kansanen E; Bonacci G; Schopfer FJ; Kuosmanen SM; Tong KI; Leinonen H; Woodcock SR; Yamamoto M; Carlberg C; Ylä-Herttuala S; Freeman BA; Levonen AL
    J Biol Chem; 2011 Apr; 286(16):14019-27. PubMed ID: 21357422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.